This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Nephrology Dialysis Transplantation | |
|---|---|
| Title | Nephrology Dialysis Transplantation |
| Discipline | Nephrology |
| Abbreviation | NDT |
| Publisher | European Renal Association–European Dialysis and Transplant Association |
| History | 1986–present |
| Frequency | Monthly |
Nephrology Dialysis Transplantation is a peer-reviewed medical journal focused on renal medicine addressing haemodialysis, peritoneal dialysis and transplantation with clinical, translational and epidemiological studies. The journal serves clinicians and researchers affiliated with institutions such as Charité, Mayo Clinic, Johns Hopkins Hospital and Addenbrooke's Hospital while interfacing with societies like the European Renal Association–European Dialysis and Transplant Association and the American Society of Nephrology.
Nephrology Dialysis Transplantation publishes original research, reviews and guidelines addressing topics ranging from chronic kidney disease to kidney transplantation, featuring contributions from centers including Massachusetts General Hospital, Cleveland Clinic, Mount Sinai Health System, Karolinska Institutet and Imperial College London. The journal reports registry analyses from cohorts such as the United States Renal Data System, ERA Registry, UK Renal Registry and collaborates with networks like International Society of Nephrology and ERA-EDTA. Editorial leadership has included figures associated with Oxford University, University of Cambridge, UCSF and University of Toronto.
Established in the mid-1980s, the journal evolved alongside advances at institutions such as Stanford, University of Pennsylvania and Yale, reflecting shifts in practice driven by trials from groups like the Dialysis Outcomes and Practice Patterns Study and landmark studies from teams at Vanderbilt, Beth Israel Deaconess Medical Center and Brigham and Women's Hospital. The scope encompasses clinical nephrology, dialysis modalities, transplant immunology and health services research intersecting with registries and agencies including WHO, European Commission health initiatives and national agencies such as NHS England and the CDC.
Content informs practice at centers including Guy's and St Thomas' NHS Foundation Trust, Papworth Hospital, Royal Brisbane and Women's Hospital, Singapore General Hospital and St. Michael's Hospital, covering haemodialysis schedules, vascular access strategies developed in units like Fresenius Medical Care clinics and transplant immunosuppression regimens influenced by research at Mayo Clinic and Johns Hopkins Hospital. Articles address complications managed with multidisciplinary teams drawing on expertise from Karolinska University Hospital, Hôpital Necker–Enfants Malades, Hospital Clínic de Barcelona and protocols referenced by EMA and FDA.
The journal publishes randomized controlled trials, cohort studies and meta-analyses by investigators from University of Oxford, McMaster University, ETH Zurich, University of Melbourne and Seoul National University Hospital, and disseminates guideline updates paralleling recommendations from KDIGO, European Renal Association–European Dialysis and Transplant Association and specialty task forces associated with American Transplantation Society. High-impact reports have cited work from research groups at Karolinska Institutet, Mount Sinai, UCSF and collaborative consortia like TRANSPLANTLines and large registries including ANZDATA and SRTR.
The journal supports continuing education for trainees and faculty linked to programs at Harvard Medical School, University College London, University of Edinburgh and University of Michigan Medical School, and aligns with professional organizations such as the European Renal Association–European Dialysis and Transplant Association, American Society of Nephrology, International Society of Nephrology, British Renal Society and regional bodies like Asian Pacific Society of Nephrology. Editorial boards commonly include members affiliated with Johns Hopkins School of Medicine, University of Toronto Faculty of Medicine, University of Amsterdam and Leiden University Medical Center.
Coverage highlights innovations from industry and academia including advancements in dialysis membranes developed by companies like Baxter International, Fresenius Medical Care and collaborations with engineering groups at MIT, ETH Zurich and Delft University of Technology. Therapeutic advances reported include novel immunosuppressants trialed in centers such as Cleveland Clinic, gene- and cell-based therapies investigated at UCLA Health, and bioengineering approaches from Wake Forest Institute for Regenerative Medicine and Wyss Institute.
The journal addresses disparities and policy strategies affecting care delivery in regions including Sub-Saharan Africa, South Asia, Latin America and partnerships with global agencies like World Health Organization, World Bank and initiatives by Bill & Melinda Gates Foundation and Global Alliance for Chronic Diseases. Policy-relevant analyses reference national programs such as Medicaid and Medicare in the United States, reimbursement models in Germany, France and Japan, and capacity-building efforts involving Doctors Without Borders, International Society of Nephrology and regional ministries of health.
Category:Medical journals Category:Nephrology